Changes in peripheral immune cells after intraoperative radiation therapy in low-risk breast cancer

dc.contributor.authorLinares Galiana, Isabel
dc.contributor.authorBerenguer Francés, Miguel Ángel
dc.contributor.authorCañas Cortés, Rut
dc.contributor.authorPujol Canadell, Monica
dc.contributor.authorComas Antón, Silvia
dc.contributor.authorMartínez, Evelyn
dc.contributor.authorLaplana, Maria
dc.contributor.authorPérez Montero, Héctor
dc.contributor.authorPla Farnós, María Jesús
dc.contributor.authorNavarro Martín, Arturo
dc.contributor.authorNuñez, Miriam
dc.contributor.authorBoth, Brigitte
dc.contributor.authorGuedea Edo, Ferran
dc.date.accessioned2021-03-01T08:57:50Z
dc.date.available2021-03-01T08:57:50Z
dc.date.issued2021-01
dc.date.updated2021-03-01T08:57:50Z
dc.description.abstractA detailed understanding of the interactions and the best dose-fractionation scheme of radiation to maximize antitumor immunity have not been fully established. In this study, the effect on the host immune system of a single dose of 20 Gy through intraoperative radiation therapy (IORT) on the surgical bed in low-risk breast cancer patients undergoing conserving breast cancer has been assessed. Peripheral blood samples from 13 patients were collected preoperatively and at 48 h and 3 and 10 weeks after the administration of radiation. We performed a flow cytometry analysis for lymphocyte subpopulations, natural killer cells (NK), regulatory T cells (Treg) and myeloid-derived suppressor cells (MDSCs). We observed that the subpopulation of NK CD56+high CD16+ increased significantly at 3 weeks after IORT (0.30-0.42%, P < 0.001), while no changes were found in immunosuppressive profile, CD4+CD25+Foxp3+Helios+ Treg cells, granulocytic MDSCs (G-MDSCs) and monocytic MDSCs (Mo-MDSCs). A single dose of IORT may be an effective approach to improve antitumor immunity based on the increase in NK cells and the non-stimulation of immunosuppressive cells involved in immune escape. These findings support future combinations of IORT with immunotherapy, if they are confirmed in a large cohort of breast cancer patients.
dc.format.extent9 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec707070
dc.identifier.issn0449-3060
dc.identifier.pmid33006364
dc.identifier.urihttps://hdl.handle.net/2445/174434
dc.language.isoeng
dc.publisherOxford University Press
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1093/jrr/rraa083
dc.relation.ispartofJournal of Radiation Research, 2021, vol. 62, num. 1, p. 110-118
dc.relation.urihttps://doi.org/10.1093/jrr/rraa083
dc.rightscc-by (c) Linares Galiana, Isabel et al., 2021
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es
dc.sourceArticles publicats en revistes (Ciències Clíniques)
dc.subject.classificationCàncer de mama
dc.subject.classificationRadioteràpia
dc.subject.classificationImmunoteràpia
dc.subject.otherBreast cancer
dc.subject.otherRadiotherapy
dc.subject.otherImmunotheraphy
dc.titleChanges in peripheral immune cells after intraoperative radiation therapy in low-risk breast cancer
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
707070.pdf
Mida:
1.34 MB
Format:
Adobe Portable Document Format